KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Investments/Divestments 8-K Filing 2024 - Press Release Kiniksa Pharmaceuticals announced plans for a Phase 2b clinical trial, topline data from a Phase 2 trial, and expected cash flow positivity.Get access to all SEC 8-K filings of the KINIKSA PHARMACEUTICALS INTERNATIONAL PLC